.png)
THE FUTURE OF BRAIN HEALTH IS HERE
Bringing Psychedelic Medicine To The Masses Through Data
EHAVE
We’re Changing the Way the World Thinks About Psychedelics
Standing on the shoulders of technology, we can lead happier and healthier lives. Ehave is investing and building the future of medicine and it is built around you.
PORTFOLIO
We Deliver An Exceptional Portfolio Of Products & Services Around the Psychedelic Industry
KetaDash
All Mental Health professionals agree the best treatment for individuals is in their secured space, getting to a clinic is a journey when dealing with depression, anxiety, and palliative care. KetaDash brings the treatment right to your door.
MYCOTOPIA
THERAPIES
Mycotopia Therapies seeks to develop regulatory approved, plant-derived, psychoactive therapeutic treatment options, and non-psychoactive nutritional supplements. Mycotopia Therapies builds and acquires retreats that specialize in depression, anxiety, and palliative care through psychedelics
METAHEALTHU
The "Human API" is the final frontier of healthcare. Current health data lives in many "data silos" looked at as software. The link to unlock the secrets of living a happier and healthier life is created from the data that you produce every day. From your genomics to your everyday behaviors, MetaHealthU pulls all that data together to describe you.
WHY EHAVE
A technology approach, to the age old method of healing with Psychedelics.
Ehave knows psychedelics healing properties, but what we want to ensure through our technology is that you get a journey specialized for "you" from your data.
Brain Health In Numbers
1 in 4
AMERICANS HAVE A MENTAL DISORDER AFFLICTION
9.5%
AMERICAN 18 & OVER SUFFER FROM DEPRESSIVE ILLNESS
26%
OF AMERICANS HAVE MENTAL HEALTH DISORDER
18%
18-54 HAVE AN ANXIETY DISORDER
INDUSTRY
Our
Partners
Our partners are the future of psychedelics powered by technology. Investing in technologies that are powered by the "Human API" is the future of brain health.
